Journal of Molecular Medicine, Genetics and Therapeutic Research is a peer-reviewed, open-access publication dedicated to advancing the understanding of human health and disease through cutting-edge research in molecular biology, medical genetics, and therapeutic innovation. The journal offers a platform for the integration of scientific discoveries with translational applications, fostering interdisciplinary collaboration across clinical medicine, biotechnology, and genomic sciences. It aims to bridge the gap between molecular mechanisms and real-world therapeutic strategies, contributing to the development of personalized medicine, novel diagnostics, and targeted treatment approaches.

The journal welcomes contributions from across the world, promoting international collaboration and fostering an inclusive scholarly exchange. From foundational studies in gene expression and epigenetics to applied research in pharmacogenomics, gene therapy, and clinical trials, the journal provides a critical forum for both theoretical and practical advancements in the biomedical sciences. With a strong emphasis on scientific rigor, ethical standards, and clinical relevance, the journal serves as a vital resource for researchers, healthcare professionals, academic institutions, and policymakers working at the intersection of biology and medicine.

Scope and Coverage

The Journal of Molecular Medicine, Genetics and Therapeutic Research publishes original research articles, comprehensive reviews, and case-based studies covering a wide spectrum of topics, including but not limited to:

• Molecular mechanisms of disease and cell signaling pathways
• Human and medical genetics, including genomic variation and population genetics
• Gene therapy, RNA-based therapeutics, and genetic editing technologies (e.g., CRISPR)
• Translational research and biomarker discovery
• Pharmacogenomics and drug response variability
• Mitochondrial genetics and inherited metabolic disorders
• Cancer genomics and personalized oncology
• Clinical trials involving molecularly targeted therapies
• Regulatory, ethical, and bioinformatics aspects of genomics and gene-based interventions

By publishing research that spans basic science and clinical application, the journal promotes the development of diagnostic tools, therapeutic interventions, and preventive strategies grounded in molecular understanding. The content is curated to support the progression from bench to bedside, helping transform scientific insights into meaningful patient outcomes.

Editorial Standards and Peer Review

Maintaining the highest standards of academic publishing, the journal follows a rigorous double-blind peer review process. Each submission undergoes an initial screening by the editorial board to ensure thematic relevance, followed by evaluation by domain-specific reviewers. The peer review process emphasizes methodological clarity, scientific validity, and originality of findings. Reviewers are selected from a global pool of scholars and clinicians with established expertise in relevant fields of molecular medicine and genetics.

The journal's editorial policies uphold integrity, transparency, and inclusivity. All published content is reviewed in accordance with international guidelines for ethical research and publication. Studies involving human participants or genetic data must include appropriate ethical approvals and informed consent documentation. The editorial team is committed to timely feedback, clear communication, and fair evaluation for all submitted manuscripts.

Open Access Policy and Dissemination

As part of the VJ Research Hub’s commitment to knowledge accessibility, the journal operates under a full open-access publishing model. All published articles are made freely available without restriction or subscription barriers. Authors retain copyright and articles are distributed under a Creative Commons license, ensuring wide dissemination and reuse within academic and clinical communities.

Open access facilitates the global exchange of knowledge, particularly in fields that are rapidly evolving and require immediate access to new findings. By eliminating financial and geographical barriers, the journal supports equitable access to research for scientists, students, medical professionals, and institutional stakeholders worldwide.

Indexing and Archiving

To maximize visibility and long-term preservation, the journal is in the process of being indexed in major academic databases, digital libraries, and citation platforms. Accepted articles will be archived in repositories that guarantee permanent access and digital integrity. The editorial office is committed to expanding the journal’s reach through indexing in leading biomedical and life sciences databases.

Global Participation and Community Engagement

The journal encourages active participation from researchers across diverse geographic, institutional, and disciplinary backgrounds. It seeks to build a collaborative academic community that addresses pressing global health challenges through molecular and genetic research. Contributions from early-career scientists, interdisciplinary teams, and clinical researchers are particularly encouraged.

Regular thematic issues, invited editorials, and special sections will focus on emerging areas such as rare genetic diseases, molecular diagnostics, therapeutic biotechnology, and personalized medicine frameworks. Through this inclusive and evolving editorial approach, the journal aims to remain responsive to developments in science and responsive to the needs of the healthcare ecosystem.

The Journal of Molecular Medicine, Genetics and Therapeutic Research remains dedicated to advancing knowledge, informing practice, and supporting the development of innovative health interventions through high-quality, peer-reviewed research in molecular and genetic sciences.